Macmillan Immunotherapy

You will be responsible for managing outpatient clinics to support the management and monitoring of patients on abemaciclib. This is an oral treatment that patients can self-administer but requires close monitoring due to the toxicities and side effects. Follow up protocol is monthly for six months followed by bi-monthly until end of treatment (two years).

National data suggests that 70% of all breast cancer patients have hormone receptor-positive HER2-negative node-positive cancer with 30% at high risk of recurrence. Torbay and South Devon NHS Trust are anticipating 50 patients per year will be eligible for abemaciclib treatment.

To manage the minimum expected demand the post holder will provide circa 550 outpatient reviews per year (equivalent to 94 outpatient clinics). In addition to the patient facing activity, you will be required to collect clinical data and outcomes for all patients receiving abemaciclib to inform business planning and service developments needs to substantiate the service.

The role of the SACT CNS/AHP will be to provide clinical review and follow up for breast patients receiving abemaciclib.

The Cancer Immunotherapy service is part of the SACT delivery service team within Oncology at TSD NHS Trust is committed to personal and professional development of staff and services. We are committed to the improvement of patient care.

The Advanced Clinical Nurse Specialist role is recognised Nationally within Cancer and Palliative care nursing and medical workforce framework as key to providing focused innovative specialist care to patient with a life changing diagnosis

The development of increasingly advanced nurse led services is key to facilitating the evolving and increasingly complex cancer and Long term condition management pathway

Full Vacancy details can be found on the attached Job Description/Person Specification. Please refer to your suitability to the post in your supporting information from the role requirements or person specification.

caretojoinus